Latest News & Features
Americas
Payout and licensing deal grants US rights to COVID-19 and flu products | Agreement paves way for BioNTech’s $1.25 billion acquisition of CureVac. 8 August 2025
Europe
Captisol dispute intensifies as Italian court sides with Bexson | CyDex claims of trade secret misuse dismissed in early-stage ruling | Case relates to ongoing US dispute. 7 August 2025
Big Pharma
With AI accelerating drug development, pharma companies must rethink how they protect models, data, and innovation, say Camille Terfve and Sean Jauss of Mewburn Ellis. 6 August 2025
Careers
A litigator, who led the Unified Patent Court group at his previous firm, brings experience spanning the physics, software, and medical device sectors. 6 August 2025
Europe
A much-anticipated referral could upend the EPO’s controversial description amendment rule—and reshape European patent practice, as the Enlarged Board of Appeal prepares to weigh in on G 1/25. 5 August 2025
Europe
UK Court of Appeal upholds key Moderna patent against Pfizer and BioNTech | Comirnaty vaccine ruled to infringe European mRNA technology patent. 4 August 2025
Unified Patent Court
Powell Gilbert experts share insights on how the Unified Patent Court is taking shape after two years in operation, in this session from LSPN. 4 August 2025
Europe
German Federal Patent Court invalidates key patent for Xarelto | Bayer faces intensifying generic competition across Europe | Legal team highlights Germany’s crucial role in patent litigation and the importance of stopping early generic entry to protect market exclusivity. 1 August 2025
Americas
Settlement ends expectations of SCOTUS petition | Federal Circuit stipulates patents must explicitly claim the active ingredient of a drug to qualify for Orange Book listing | FTC backs Amneal, saying ‘improper listings’ stifle generic competition. 31 July 2025
Europe
The pharma manufacturer defeats an Italian hemp firm’s EU trademark bid | Claimed name could be confused for its blockbuster drug Xanax | EUIPO found strong market position and product overlap created risk of confusion. 31 July 2025